Asthma and COPD share similar breathing symptoms, often leading to confusion and misdiagnosis. Know key differences, risks of ...

New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are ...

CEO Barry Quart told investors at Oppenheimer’s 36th Annual Healthcare Life Science Conference that the company is advancing ...

Proton pump inhibitor (PPI) use in patients with chronic obstructive airway diseases is associated with an increased exacerbation risk.

Results showed that a dry powder inhaler loaded with umeclidinium and vilanterol produced a 14% lower risk of moderate or severe COPD flare-ups, compared to a metered-dose inhaler loaded with ...

Both dupilumab and mepolizumab were originally approved for asthma but were subsequently studied in patients with COPD who continue to experience symptoms and moderate-to-severe exacerbations despite ...

Findings based on comparison to glycopyrrolate-formoterol and tiotropium-olodaterol in patients newly prescribed LAMA-LABA inhalers.

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that include chronic bronchitis and emphysema. It’s a chronic condition that makes breathing difficult, and can lead to ...

Quitting smoking and avoiding vaping may be crucial steps in managing COPD, as these habits expose your lungs to irritants that cause further damage. Quitting may slow the disease’s progression and ...

Elastic parametric response mapping (ePRM), a CT-based severity scoring system for regional lung volumes, can monitor COPD progression.

COPD affects at least 4.5% of those 18-49 years old, according to an analysis of U.S. cohorts. The early COPD group was more likely to be hospitalized or die from chronic respiratory disease, to ...